The AI Trust Tax: Why Healthcare’s Biggest AI Barrier Isn’t Technology

AI is reshaping how healthcare work gets done, but the biggest obstacle to adoption isn’t the technology itself. It’s earning the trust of the clinicians and administrators who have to use it. Excell Healthcare Advisors calls this the “AI Trust Tax”: the investment organizations must make in people and process to turn technical capability into […]
Why every city and county needs a strategic plan for government properties

Aging facilities, changing public service needs and increased uncertainty surrounding Federal and State budgets have made a proactive real estate strategy an urgent imperative. City and county governments are facing increasing pressure from aging facilities, budget uncertainty, deferred maintenance, workforce changes and evolving community needs. Yet many municipalities lack a comprehensive strategy for managing one […]
Five questions every government facilities leader should be asking

What modern facilities management actually delivers for the government. Government facilities leaders are being asked to do more with aging assets, limited budgets, workforce transitions, and growing expectations for operational performance. At the same time, deferred maintenance backlogs and technology gaps continue to increase risk across public sector portfolios. This guide explores five critical questions […]
5 Hidden Costs of Fragmented T&E spend

When inefficiencies creep into the T&E process, they can come with costs that aren’t readily apparent. That may be holding your program back — and hurting the company’s bottom line. Uncovering these roadblocks is the first step in creating efficiencies that could save everyone involved — travel and finance managers, as well as travelers — […]
3 Key Steps to Achieve AI-Driven Financial Control

Let’s face it: Amassing AI tools is not an AI strategy. But a mandate to be “AI-first” has led many companies to do just that — even when foundational data problems exist that prevent full use of those tools. Flipping the script is why we created the Finance AI Pyramid Framework — three layers of […]
How the best HR leaders evaluate benefits

The women’s and family health benefits market has grown increasingly complex. All of the vendors are making the same promises about comprehensive solutions, large provider networks, and improved outcomes. Many employers believe they’re forced to make trade-offs: lower cost or better care, technology or human support, global scale or local expertise. In reality, those trade-offs […]
Understanding the ROI of Leave Management Solutions

The Leave Management ROI Guide provides a quick overview of the main components of a leave solution’s ROI, including: Administrative and legal cost savings Recruiting and retention cost savings Leave technology HR efficiency savings Leave management solution costs In this guide, you’ll learn how to determine and compare the ROI of competing leave management solutions […]
The Family Medical Leave Act (FMLA) Employer Handbook

Leave and absence management is changing as regulations change and employee demand for strong leave programs increases. Yet for many employers, the complexities of the Family and Medical Leave Act can make adapting to the current leave landscape a difficult task. Our updated 2021 FMLA guide will help employers and their HR professionals understand and […]
Attendant Console for Microsoft Teams: How Reception Teams Connect Callers Faster

It combines caller identification, directory search, real-time presence, calendar visibility, and one-click transfers in a single view, so front-desk teams can connect each caller to the right person on the first try instead of searching across three or four separate windows.
The Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific (APAC) Markets

As Asia-Pacific (APAC) markets grapple with rapidly aging populations and healthcare resource constraints, conventional budget impact and cost-effectiveness models often fall short in capturing the full picture of pharmaceutical innovation.